Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Thrombopoietin (TPO) can activate hematopoietic cell proliferation by its receptor c-MPL mediated downstream pathways and induce the generation of megakaryocyte. In recent years, domestic and foreign researches have confirmed that TPO/ c-MPL pathway also plays an important role in the self-renewal and quiescence of leukemia stem cell, and its expression in acute myeloid leukemia (AML) also indicates the chemotherapy resistance and poor prognosis. In this article, the research progress of the roles of TPO/c-MPL pathway in chemotherapy resistance, prognosis of AML patients, and the application of TPO/ c-MPL receptor agonists in AML were summarized briefly.

Citation

Nan Wang, Hai-Yan Zhu. Research Status of TPO/c-MPL Signaling Pathway in Acute Myeloid Leukemia--Review]. Zhongguo shi yan xue ye xue za zhi. 2021 Aug;29(4):1351-1354

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 34362529

View Full Text